Back to search
FDAFDA · Food and drugs·Recall number D-0047-2025

IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05

Published November 27, 2024 · Recall initiated: October 29, 2024

Summary

FDA records drug Class III recall D-0047-2025, published November 27, 2024 and initiated October 29, 2024. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Ongoing; Reported quantity: 3416 botttles; Lot: Lot #: C5406201, Exp 03/31/2028. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications

What to do

Voluntary: Firm initiated

Get an email if IBU has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
IBU
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
USA Nationwide
Lot
Lot #: C5406201, Exp 03/31/2028
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05 recalled?

Yes. FDA published recall D-0047-2025 on November 27, 2024. Reported hazard: Failed Tablet/Capsule Specifications

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: IBU.